{"SPADE_UN_16128": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16128", "Peptide Name": "A3", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "RKLILKRKRILIKR", "Sequence Length": 14, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:U-937 (LD50>64 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C84H164N30O15", "Mass": 1834.39, "PI": 12.0, "Net Charge": 8, "Hydrophobicity": -0.62, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Literature": [{"Title": "Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties", "Pubmed ID": "25192319", "Reference": "Mol Pharm. 2014 Oct 6;11(10)3492-502.", "Author": "Rapsch K, Bier FF, von Nickisch-Rosenegk M.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25192319"}], "Frequent Amino Acids": "KRI", "Absent Amino Acids": "ACDEFGHMNOPQSTUVWY", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 8, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_02234", "Similarity": 1.0, "Sequence": "FDRAGRKLI"}, {"SPADE_ID": "SPADE_UN_15534", "Similarity": 1.0, "Sequence": "SLLSLFRKLI"}, {"SPADE_ID": "SPADE_UN_16015", "Similarity": 1.0, "Sequence": "RLLRLIRKLIL"}]}}}